Clinical and Genetic Heterogeneity, Overlap with Other Tumor Syndromes, and Atypical Glucocorticoid Hormone Secretion in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Compared with Other Adrenocortical Tumors
Objective: ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing’s syndrome (CS). We characterized a large series of patients of AIMAH and compared them with patients with other adrenocortical tumors. Design and Patients...
Saved in:
| Published in | The journal of clinical endocrinology and metabolism Vol. 94; no. 8; pp. 2930 - 2937 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Bethesda, MD
Oxford University Press
01.08.2009
Endocrine Society The Endocrine Society |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0021-972X 1945-7197 1945-7197 |
| DOI | 10.1210/jc.2009-0516 |
Cover
| Abstract | Objective: ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing’s syndrome (CS). We characterized a large series of patients of AIMAH and compared them with patients with other adrenocortical tumors.
Design and Patients: We recruited 82 subjects with: 1) AIMAH (n = 16); 2) adrenocortical cortisol-producing adenoma with CS (n = 15); 3) aldosterone-producing adenoma (n = 19); and 4) single adenomas with clinically nonsignificant cortisol secretion (n = 32).
Methods: Urinary free cortisol (UFC) and 17-hydroxycorticosteroid (17OHS) were collected at baseline and during dexamethasone testing; aberrant receptor responses was also sought by clinical testing and confirmed molecularly. Peripheral and/or tumor DNA was sequenced for candidate genes.
Results: AIMAH patients had the highest 17OHS excretion, even when UFCs were within or close to the normal range. Aberrant receptor expression was highly prevalent. Histology showed at least two subtypes of AIMAH. For three patients with AIMAH, there was family history of CS; germline mutations were identified in three other patients in the genes for menin (one), fumarate hydratase (one), and adenomatosis polyposis coli (APC) (one); a PDE11A gene variant was found in another. One patient had a GNAS mutation in adrenal nodules only. There were no mutations in any of the tested genes in the patients of the other groups.
Conclusions: AIMAH is a clinically and genetically heterogeneous disorder that can be associated with various genetic defects and aberrant hormone receptors. It is frequently associated with atypical CS and increased 17OHS; UFCs and other measures of adrenocortical activity can be misleadingly normal. |
|---|---|
| AbstractList | Objective: ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing’s syndrome (CS). We characterized a large series of patients of AIMAH and compared them with patients with other adrenocortical tumors. Design and Patients: We recruited 82 subjects with: 1) AIMAH (n = 16); 2) adrenocortical cortisol-producing adenoma with CS (n = 15); 3) aldosterone-producing adenoma (n = 19); and 4) single adenomas with clinically nonsignificant cortisol secretion (n = 32). Methods: Urinary free cortisol (UFC) and 17-hydroxycorticosteroid (17OHS) were collected at baseline and during dexamethasone testing; aberrant receptor responses was also sought by clinical testing and confirmed molecularly. Peripheral and/or tumor DNA was sequenced for candidate genes. Results: AIMAH patients had the highest 17OHS excretion, even when UFCs were within or close to the normal range. Aberrant receptor expression was highly prevalent. Histology showed at least two subtypes of AIMAH. For three patients with AIMAH, there was family history of CS; germline mutations were identified in three other patients in the genes for menin (one), fumarate hydratase (one), and adenomatosis polyposis coli (APC) (one); a PDE11A gene variant was found in another. One patient had a GNAS mutation in adrenal nodules only. There were no mutations in any of the tested genes in the patients of the other groups. Conclusions: AIMAH is a clinically and genetically heterogeneous disorder that can be associated with various genetic defects and aberrant hormone receptors. It is frequently associated with atypical CS and increased 17OHS; UFCs and other measures of adrenocortical activity can be misleadingly normal. Objective: ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing’s syndrome (CS). We characterized a large series of patients of AIMAH and compared them with patients with other adrenocortical tumors. Design and Patients: We recruited 82 subjects with: 1) AIMAH (n = 16); 2) adrenocortical cortisol-producing adenoma with CS (n = 15); 3) aldosterone-producing adenoma (n = 19); and 4) single adenomas with clinically nonsignificant cortisol secretion (n = 32). Methods: Urinary free cortisol (UFC) and 17-hydroxycorticosteroid (17OHS) were collected at baseline and during dexamethasone testing; aberrant receptor responses was also sought by clinical testing and confirmed molecularly. Peripheral and/or tumor DNA was sequenced for candidate genes. Results: AIMAH patients had the highest 17OHS excretion, even when UFCs were within or close to the normal range. Aberrant receptor expression was highly prevalent. Histology showed at least two subtypes of AIMAH. For three patients with AIMAH, there was family history of CS; germline mutations were identified in three other patients in the genes for menin (one), fumarate hydratase (one), and adenomatosis polyposis coli ( APC ) (one); a PDE11A gene variant was found in another. One patient had a GNAS mutation in adrenal nodules only. There were no mutations in any of the tested genes in the patients of the other groups. Conclusions: AIMAH is a clinically and genetically heterogeneous disorder that can be associated with various genetic defects and aberrant hormone receptors. It is frequently associated with atypical CS and increased 17OHS; UFCs and other measures of adrenocortical activity can be misleadingly normal. ACTH-independent macronodular adrenal hyperplasia is a heterogeneous disorder often associated with genetic defects at the germline or the somatic level. ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing's syndrome (CS). We characterized a large series of patients of AIMAH and compared them with patients with other adrenocortical tumors. We recruited 82 subjects with: 1) AIMAH (n = 16); 2) adrenocortical cortisol-producing adenoma with CS (n = 15); 3) aldosterone-producing adenoma (n = 19); and 4) single adenomas with clinically nonsignificant cortisol secretion (n = 32). Urinary free cortisol (UFC) and 17-hydroxycorticosteroid (17OHS) were collected at baseline and during dexamethasone testing; aberrant receptor responses was also sought by clinical testing and confirmed molecularly. Peripheral and/or tumor DNA was sequenced for candidate genes. AIMAH patients had the highest 17OHS excretion, even when UFCs were within or close to the normal range. Aberrant receptor expression was highly prevalent. Histology showed at least two subtypes of AIMAH. For three patients with AIMAH, there was family history of CS; germline mutations were identified in three other patients in the genes for menin (one), fumarate hydratase (one), and adenomatosis polyposis coli (APC) (one); a PDE11A gene variant was found in another. One patient had a GNAS mutation in adrenal nodules only. There were no mutations in any of the tested genes in the patients of the other groups. AIMAH is a clinically and genetically heterogeneous disorder that can be associated with various genetic defects and aberrant hormone receptors. It is frequently associated with atypical CS and increased 17OHS; UFCs and other measures of adrenocortical activity can be misleadingly normal. ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing's syndrome (CS). We characterized a large series of patients of AIMAH and compared them with patients with other adrenocortical tumors.OBJECTIVEACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing's syndrome (CS). We characterized a large series of patients of AIMAH and compared them with patients with other adrenocortical tumors.We recruited 82 subjects with: 1) AIMAH (n = 16); 2) adrenocortical cortisol-producing adenoma with CS (n = 15); 3) aldosterone-producing adenoma (n = 19); and 4) single adenomas with clinically nonsignificant cortisol secretion (n = 32).DESIGN AND PATIENTSWe recruited 82 subjects with: 1) AIMAH (n = 16); 2) adrenocortical cortisol-producing adenoma with CS (n = 15); 3) aldosterone-producing adenoma (n = 19); and 4) single adenomas with clinically nonsignificant cortisol secretion (n = 32).Urinary free cortisol (UFC) and 17-hydroxycorticosteroid (17OHS) were collected at baseline and during dexamethasone testing; aberrant receptor responses was also sought by clinical testing and confirmed molecularly. Peripheral and/or tumor DNA was sequenced for candidate genes.METHODSUrinary free cortisol (UFC) and 17-hydroxycorticosteroid (17OHS) were collected at baseline and during dexamethasone testing; aberrant receptor responses was also sought by clinical testing and confirmed molecularly. Peripheral and/or tumor DNA was sequenced for candidate genes.AIMAH patients had the highest 17OHS excretion, even when UFCs were within or close to the normal range. Aberrant receptor expression was highly prevalent. Histology showed at least two subtypes of AIMAH. For three patients with AIMAH, there was family history of CS; germline mutations were identified in three other patients in the genes for menin (one), fumarate hydratase (one), and adenomatosis polyposis coli (APC) (one); a PDE11A gene variant was found in another. One patient had a GNAS mutation in adrenal nodules only. There were no mutations in any of the tested genes in the patients of the other groups.RESULTSAIMAH patients had the highest 17OHS excretion, even when UFCs were within or close to the normal range. Aberrant receptor expression was highly prevalent. Histology showed at least two subtypes of AIMAH. For three patients with AIMAH, there was family history of CS; germline mutations were identified in three other patients in the genes for menin (one), fumarate hydratase (one), and adenomatosis polyposis coli (APC) (one); a PDE11A gene variant was found in another. One patient had a GNAS mutation in adrenal nodules only. There were no mutations in any of the tested genes in the patients of the other groups.AIMAH is a clinically and genetically heterogeneous disorder that can be associated with various genetic defects and aberrant hormone receptors. It is frequently associated with atypical CS and increased 17OHS; UFCs and other measures of adrenocortical activity can be misleadingly normal.CONCLUSIONSAIMAH is a clinically and genetically heterogeneous disorder that can be associated with various genetic defects and aberrant hormone receptors. It is frequently associated with atypical CS and increased 17OHS; UFCs and other measures of adrenocortical activity can be misleadingly normal. Objective: ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing’s syndrome (CS). We characterized a large series of patients of AIMAH and compared them with patients with other adrenocortical tumors. Design and Patients: We recruited 82 subjects with: 1) AIMAH (n = 16); 2) adrenocortical cortisol-producing adenoma with CS (n = 15); 3) aldosterone-producing adenoma (n = 19); and 4) single adenomas with clinically nonsignificant cortisol secretion (n = 32). Methods: Urinary free cortisol (UFC) and 17-hydroxycorticosteroid (17OHS) were collected at baseline and during dexamethasone testing; aberrant receptor responses was also sought by clinical testing and confirmed molecularly. Peripheral and/or tumor DNA was sequenced for candidate genes. Results: AIMAH patients had the highest 17OHS excretion, even when UFCs were within or close to the normal range. Aberrant receptor expression was highly prevalent. Histology showed at least two subtypes of AIMAH. For three patients with AIMAH, there was family history of CS; germline mutations were identified in three other patients in the genes for menin (one), fumarate hydratase (one), and adenomatosis polyposis coli (APC) (one); a PDE11A gene variant was found in another. One patient had a GNAS mutation in adrenal nodules only. There were no mutations in any of the tested genes in the patients of the other groups. Conclusions: AIMAH is a clinically and genetically heterogeneous disorder that can be associated with various genetic defects and aberrant hormone receptors. It is frequently associated with atypical CS and increased 17OHS; UFCs and other measures of adrenocortical activity can be misleadingly normal. |
| Author | Boikos, Sosipatros A. Lacroix, André Hsiao, Hui-Pin Nesterova, Maria Stratakis, Constantine A. Bourdeau, Isabelle Verma, Somya Kirschner, Lawrence S. Keil, Margaret F. Robinson-White, Audrey J. |
| Author_xml | – sequence: 1 givenname: Hui-Pin surname: Hsiao fullname: Hsiao, Hui-Pin organization: 1Section on Endocrinology and Genetics (H.-P.H., S.A.B., S.V., A.J.R.-W., M.N., C.A.S.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 – sequence: 2 givenname: Lawrence S. surname: Kirschner fullname: Kirschner, Lawrence S. organization: 3Division of Endocrinology, Diabetes, and Metabolism (L.S.K.), Department of Internal Medicine, Ohio State University, Columbus, Ohio 43210 – sequence: 3 givenname: Isabelle surname: Bourdeau fullname: Bourdeau, Isabelle organization: 4Endocrinology Division (I.B., A.L.), Department of Medicine, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada H2W 1T8 – sequence: 4 givenname: Margaret F. surname: Keil fullname: Keil, Margaret F. organization: 2Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Interinstitute Training Program (M.F.K., S.V., C.A.S.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 – sequence: 5 givenname: Sosipatros A. surname: Boikos fullname: Boikos, Sosipatros A. organization: 1Section on Endocrinology and Genetics (H.-P.H., S.A.B., S.V., A.J.R.-W., M.N., C.A.S.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 – sequence: 6 givenname: Somya surname: Verma fullname: Verma, Somya organization: 1Section on Endocrinology and Genetics (H.-P.H., S.A.B., S.V., A.J.R.-W., M.N., C.A.S.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 – sequence: 7 givenname: Audrey J. surname: Robinson-White fullname: Robinson-White, Audrey J. organization: 1Section on Endocrinology and Genetics (H.-P.H., S.A.B., S.V., A.J.R.-W., M.N., C.A.S.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 – sequence: 8 givenname: Maria surname: Nesterova fullname: Nesterova, Maria organization: 1Section on Endocrinology and Genetics (H.-P.H., S.A.B., S.V., A.J.R.-W., M.N., C.A.S.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 – sequence: 9 givenname: André surname: Lacroix fullname: Lacroix, André organization: 4Endocrinology Division (I.B., A.L.), Department of Medicine, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada H2W 1T8 – sequence: 10 givenname: Constantine A. surname: Stratakis fullname: Stratakis, Constantine A. email: stratakc@mail.nih.gov organization: 1Section on Endocrinology and Genetics (H.-P.H., S.A.B., S.V., A.J.R.-W., M.N., C.A.S.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21816333$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19509103$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kktvEzEURi1URB-wY40sIWCTKX7NwxukKIKkUlEWLRI7y_HcNI5m7MGeKcrv5Y_gPFpCpW5sWT736LPvPUcnzjtA6C0ll5RR8nltLhkhMiM5LV6gMypFnpVUlifojBBGM1myn6foPMY1IVSInL9Cp1TmRFLCz9CfSWOdNbrB2tV4Cg56a_AMegj-Lp1svxnh-T2ERnf4t-1XeN6vIODbofUB32xcHXwLcbQrH_ebbueaNoPxxofk8rbGMx_aFBrfgAnJ7x22Do_rAO4B6oPvrMuuXA0dpMX1-Ls2wTtfD40OeziJZ5sOQtfoaDWe-LbTAerjWMfShO9Sxtfo5VI3Ed4c9gv049vX28ksu55Prybj68wILvqspgU1C1FUpSylkFwbwSRUdV4WplwsDWPGABGLCgRhJl1URtJcLziVteAl5xfoy97bDYsWapNeEXSjumBbHTbKa6v-v3F2pe78vWIlJ1UhkuDjQRD8rwFir1obDTSNduCHqIoyL0hVVgl8_wRc-yGkD4qK00IIWsiCJOrdcZ7HIA_dT8CHA6Bj-q5l0M7Y-MgxWtGC8y032nOpIzEGWP5TEbUdQrU2ajuEajuECWdPcGN7ve17erVtniv6tC_yQ_ecfjfj_C-HNfHJ |
| CODEN | JCEMAZ |
| CitedBy_id | crossref_primary_10_1210_jc_2016_3908 crossref_primary_10_3803_EnM_2011_26_1_1 crossref_primary_10_1530_EJE_17_0873 crossref_primary_10_14366_usg_19029 crossref_primary_10_1186_s12902_019_0345_8 crossref_primary_10_1016_j_ecl_2015_02_004 crossref_primary_10_1210_jendso_bvaa162 crossref_primary_10_1016_j_ecl_2018_02_007 crossref_primary_10_1210_jc_2014_1265 crossref_primary_10_1021_acs_jpcc_9b07053 crossref_primary_10_1016_j_beem_2020_101386 crossref_primary_10_1016_j_mce_2013_01_015 crossref_primary_10_1016_j_mce_2010_11_018 crossref_primary_10_1210_clinem_dgae419 crossref_primary_10_1586_eem_12_60 crossref_primary_10_1007_s12020_011_9490_1 crossref_primary_10_1016_j_beem_2020_101428 crossref_primary_10_1056_NEJMoa1304603 crossref_primary_10_1530_EJE_13_0308 crossref_primary_10_3389_fendo_2016_00104 crossref_primary_10_1016_j_celrep_2022_111223 crossref_primary_10_1155_2020_8848151 crossref_primary_10_1186_s13256_023_03968_0 crossref_primary_10_1371_journal_pone_0191602 crossref_primary_10_1016_j_lpm_2018_07_002 crossref_primary_10_1210_en_2014_1122 crossref_primary_10_1210_jc_2013_4237 crossref_primary_10_14341_probl13301 crossref_primary_10_1016_j_coemr_2024_100541 crossref_primary_10_1210_jc_2010_1222 crossref_primary_10_1530_EJE_15_0642 crossref_primary_10_1210_jc_2018_02638 crossref_primary_10_1016_j_jsbmb_2019_105410 crossref_primary_10_3389_fendo_2016_00111 crossref_primary_10_1016_j_clinbiochem_2018_06_013 crossref_primary_10_1016_j_rceng_2022_01_003 crossref_primary_10_1155_2012_503290 crossref_primary_10_1158_1078_0432_CCR_10_1497 crossref_primary_10_3389_fendo_2022_931389 crossref_primary_10_1007_s12022_023_09751_7 crossref_primary_10_3389_fendo_2016_00093 crossref_primary_10_1210_jc_2016_1874 crossref_primary_10_1210_jendso_bvaa075 crossref_primary_10_1016_S0140_6736_14_61375_1 crossref_primary_10_1093_hmg_ddq014 crossref_primary_10_1016_j_beem_2018_01_003 crossref_primary_10_1530_EJE_12_0594 crossref_primary_10_1210_endrev_bnac034 crossref_primary_10_1186_s13256_015_0757_7 crossref_primary_10_1210_er_2017_00189 crossref_primary_10_1556_650_2023_32817 crossref_primary_10_1186_s13023_025_03554_1 crossref_primary_10_1016_j_mce_2013_10_028 crossref_primary_10_1093_hmg_ddx235 crossref_primary_10_1016_j_rce_2022_01_003 crossref_primary_10_1016_j_ecl_2016_01_006 crossref_primary_10_1016_j_ecl_2017_01_007 crossref_primary_10_1055_a_1061_7349 crossref_primary_10_1016_j_path_2019_08_005 crossref_primary_10_3390_biomedicines10051041 crossref_primary_10_1016_S0084_3741_10_79581_0 crossref_primary_10_1210_js_2019_00210 crossref_primary_10_1111_cen_12763 crossref_primary_10_1056_NEJMe1312792 crossref_primary_10_1097_MED_0000000000000725 crossref_primary_10_1038_nrendo_2016_24 crossref_primary_10_1056_NEJMoa1215245 crossref_primary_10_1055_a_2359_8051 crossref_primary_10_1055_a_1804_6047 crossref_primary_10_3389_fendo_2023_1329082 crossref_primary_10_1530_EJE_10_0195 crossref_primary_10_3390_ijms252111341 crossref_primary_10_53730_ijhs_v5nS1_15303 crossref_primary_10_1186_s12902_022_01022_6 crossref_primary_10_1210_jc_2010_2420 crossref_primary_10_1016_j_mce_2014_07_012 crossref_primary_10_1530_EJE_15_0532 crossref_primary_10_1210_jc_2015_2212 crossref_primary_10_1186_1750_1172_8_142 crossref_primary_10_1056_NEJMoa1310359 crossref_primary_10_1507_endocrj_EJ20_0163 crossref_primary_10_1530_EJE_18_0296 crossref_primary_10_1530_EC_22_0063 crossref_primary_10_1124_pharmrev_120_000269 crossref_primary_10_3389_fendo_2022_1073328 crossref_primary_10_1007_s12022_023_09761_5 crossref_primary_10_1007_s12020_017_1231_7 crossref_primary_10_1016_j_coemr_2019_08_007 crossref_primary_10_1530_JME_16_0188 crossref_primary_10_1530_ERC_18_0160 crossref_primary_10_1097_MOG_0b013e3283567f69 crossref_primary_10_1007_s12022_022_09710_8 crossref_primary_10_1530_EJE_15_0205 crossref_primary_10_1016_j_ajhg_2011_03_005 crossref_primary_10_1038_ng_2956 crossref_primary_10_1038_s41574_022_00718_y crossref_primary_10_1007_s12022_021_09667_0 crossref_primary_10_1210_jendso_bvac041 crossref_primary_10_4236_ojemd_2020_102003 crossref_primary_10_1093_ejendo_lvaf016 crossref_primary_10_12677_ACM_2023_13122674 crossref_primary_10_3389_fmed_2018_00054 crossref_primary_10_1007_s42000_018_0072_y crossref_primary_10_1530_EJE_15_0200 crossref_primary_10_1210_clinem_dgae918 crossref_primary_10_1210_jc_2013_1956 crossref_primary_10_3892_mmr_2022_12814 crossref_primary_10_1210_jendso_bvad025 crossref_primary_10_1093_hmg_ddq455 crossref_primary_10_1210_js_2016_1018 crossref_primary_10_1530_JOE_14_0568 crossref_primary_10_1097_MED_0000000000000061 crossref_primary_10_1016_j_ando_2024_01_005 crossref_primary_10_3390_biomedicines9101397 crossref_primary_10_1530_ERC_17_0361 crossref_primary_10_3389_fendo_2021_632543 crossref_primary_10_1007_s12020_020_02583_z crossref_primary_10_1093_ejendo_lvaf020 crossref_primary_10_1093_ejendo_lvad088 crossref_primary_10_1245_s10434_015_4605_1 |
| ContentType | Journal Article |
| Copyright | Copyright © 2009 by The Endocrine Society 2009 2009 INIST-CNRS Copyright © 2009 by The Endocrine Society Copyright © 2009 by The Endocrine Society 2009 |
| Copyright_xml | – notice: Copyright © 2009 by The Endocrine Society 2009 – notice: 2009 INIST-CNRS – notice: Copyright © 2009 by The Endocrine Society – notice: Copyright © 2009 by The Endocrine Society 2009 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM H94 K9. 7X8 5PM |
| DOI | 10.1210/jc.2009-0516 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1945-7197 |
| EndPage | 2937 |
| ExternalDocumentID | PMC2730864 19509103 21816333 10_1210_jc_2009_0516 10.1210/jc.2009-0516 |
| Genre | Comparative Study Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: Intramural NIH HHS grantid: Z01 HD000642 – fundername: NICHD NIH HHS grantid: Z01-HD-000642-04 |
| GroupedDBID | --- -~X .55 .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 4.4 48X 53G 5GY 5RS 5YH 8F7 AABZA AACZT AAIMJ AAPQZ AAPXW AARHZ AAUAY AAVAP AAWTL ABBLC ABDFA ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABVGC ABWST ABXVV ACGFO ACGFS ACPRK ACUTJ ACYHN ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK AELWJ AEMDU AENEX AENZO AERZD AETBJ AEWNT AFCHL AFFNX AFFZL AFGWE AFOFC AFRAH AFXAL AGINJ AGKRT AGQXC AGUTN AHMBA AHMMS AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT ARIXL ASPBG ATGXG AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BSWAC BTRTY C45 CDBKE CS3 D-I DAKXR DIK E3Z EBS EJD EMOBN ENERS F5P FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 HZ~ H~9 KBUDW KOP KQ8 KSI KSN L7B M5~ MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NVLIB O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G REU ROX ROZ TEORI TJX TLC TR2 TWZ VVN W8F WOQ X7M YBU YFH YHG YOC YSK ZY1 ~02 ~H1 .GJ 3O- 7X7 88E 8FI 8FJ AAJQQ AAKAS AAPGJ AAQQT AAUQX AAWDT AAYJJ AAYXX ABDPE ABUWG ABXZS ACFRR ACVCV ACZBC ADMTO ADNBA ADZCM AEMQT AEOTA AFFQV AFKRA AFYAG AGMDO AGORE AHGBF AI. AJBYB AJDVS ALXQX APJGH AQDSO AQKUS AVNTJ BENPR BPHCQ BVXVI CCPQU CITATION EIHJH FEDTE FYUFA HMCUK HVGLF IAO IHR INH ITC J5H M1P MBLQV NU- OBFPC PHGZM PHGZT PQQKQ PROAC PSQYO TMA UKHRP VH1 WHG X52 ZGI ZXP IQODW PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM AEHZK H94 K9. 7X8 5PM |
| ID | FETCH-LOGICAL-c434t-d161cb4687979493ac429e8d576c7bfc22cce04b8e402ce8d8c915ab319d43733 |
| ISSN | 0021-972X 1945-7197 |
| IngestDate | Thu Aug 21 14:13:49 EDT 2025 Sun Sep 28 10:49:41 EDT 2025 Fri Sep 19 20:52:36 EDT 2025 Mon Jul 21 06:03:51 EDT 2025 Mon Jul 21 09:16:42 EDT 2025 Tue Jul 01 04:01:32 EDT 2025 Thu Apr 24 23:03:48 EDT 2025 Fri Feb 07 10:35:43 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | Endocrinopathy Immunopathology Adrenal cortex carcinoma Obesity Adrenal cortex diseases Nutrition Secretion Nutrition disorder Autoimmune disease Metabolic diseases Hyperadrenocorticism Genetic diversity Malignant tumor Enzymopathy Glucocorticoid Congenital adrenal hyperplasia syndrome Adrenocorticotropic hormone Adenohypophyseal hormone Adrenal gland diseases Atypical Endocrinology Nutritional status Comparative study Cancer |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c434t-d161cb4687979493ac429e8d576c7bfc22cce04b8e402ce8d8c915ab319d43733 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 Address all correspondence and requests for reprints to: Constantine A. Stratakis, M.D., D(Med)Sc., Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Drive, Building 10, Clinical Research Center, Room 1-3330, MSC1103, Bethesda, Maryland 20892. E-mail: stratakc@mail.nih.gov. |
| PMID | 19509103 |
| PQID | 3164416960 |
| PQPubID | 2046206 |
| PageCount | 8 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2730864 proquest_miscellaneous_67560878 proquest_journals_3164416960 pubmed_primary_19509103 pascalfrancis_primary_21816333 crossref_primary_10_1210_jc_2009_0516 crossref_citationtrail_10_1210_jc_2009_0516 oup_primary_10_1210_jc_2009-0516 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2009-08-01 |
| PublicationDateYYYYMMDD | 2009-08-01 |
| PublicationDate_xml | – month: 08 year: 2009 text: 2009-08-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | Bethesda, MD |
| PublicationPlace_xml | – name: Bethesda, MD – name: United States – name: Washington |
| PublicationTitle | The journal of clinical endocrinology and metabolism |
| PublicationTitleAlternate | J Clin Endocrinol Metab |
| PublicationYear | 2009 |
| Publisher | Oxford University Press Endocrine Society The Endocrine Society |
| Publisher_xml | – name: Oxford University Press – name: Endocrine Society – name: The Endocrine Society |
| SSID | ssj0014453 |
| Score | 2.3678772 |
| Snippet | Objective: ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing’s syndrome... ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing's syndrome (CS). We... Objective: ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often associated with subclinical cortisol secretion or atypical Cushing’s syndrome... |
| SourceID | pubmedcentral proquest pubmed pascalfrancis crossref oup |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2930 |
| SubjectTerms | Adenoma Adenomatous polyposis coli Adrenal Cortex - pathology Adrenal Cortex Neoplasms - genetics Adrenal Cortex Neoplasms - metabolism Adrenals. Adrenal axis. Renin-angiotensin system (diseases) Adrenocorticotropic hormone Adrenocorticotropic Hormone - physiology Adult Aldosterone Biological and medical sciences Chromogranins Corticotropin-Releasing Hormone Cortisol Dexamethasone Dexamethasone - pharmacology Endocrinopathies Feeding. Feeding behavior Female Fumarase Fundamental and applied biological sciences. Psychology Genetic Heterogeneity Glucocorticoids - metabolism GTP-Binding Protein alpha Subunits, Gs - genetics Hormones Humans Hyperplasia Male Medical sciences Middle Aged Mutation Non tumoral diseases. Target tissue resistance. Benign neoplasms Nucleotide sequence Original Polyposis Polyposis coli Secretion Tumors Vertebrates: anatomy and physiology, studies on body, several organs or systems Vertebrates: endocrinology |
| Title | Clinical and Genetic Heterogeneity, Overlap with Other Tumor Syndromes, and Atypical Glucocorticoid Hormone Secretion in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Compared with Other Adrenocortical Tumors |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/19509103 https://www.proquest.com/docview/3164416960 https://www.proquest.com/docview/67560878 https://pubmed.ncbi.nlm.nih.gov/PMC2730864 |
| Volume | 94 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1945-7197 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0014453 issn: 0021-972X databaseCode: DIK dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1945-7197 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0014453 issn: 0021-972X databaseCode: GX1 dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELbaIiEkhIByBErxAzxtg3YT53pEBbQcRTy0Ut-iHI4atJuscgjB3-WPMONrndKK4yXajSe2d-eLZ8aeg5AXflAxHkUczNQAt25Cz81LHgJD8NSmYpWXYKDwyedwecY-nAfnO7v7ltfSOOSvih9XxpX8D1fhHvAVo2T_gbOmU7gBn4G_cAUOw_WveHyswxpx9xuoMCARVD_4q1r8phL-o5PmKtvILVcRcDUbxnXbmWwFvXbhzIbvG9GfcGQHuxT6a-tydgGKbQvaaI86pvaOzDAGXBMNHQZeubUpqjvM1hms8U1bCj9XQYxhl2D2dhsRunnJ_V1OzO4U3eBxnr2tQCOsrWwXJrATBm1hAWy2KaXWfACAr3SKRIQujCp2hpdj7X6pLf-DDmx8FfnzKfsmE-_apbe7kmejWE77DE9q-FZOyT10XS9YOUrrbZTEOPGBFJRLf8ICN1pIb2EtG2QBZvUOxPZCn8jjpN8kEJjQKIFEdkwYJJCRpBYYN2uBRiy_C6qav5XDxjtSN-2SG14UhliX4837j-ZsjLHAVyEcGH9lDyVS4MqHJ3qWjN28vcl64EglK7ZcZVJd9gy2VK3Tu-SOspHoawn4e2SHN_fJzRPlBbJPfmrcU-AzVbinE9wfUYV6iuCiAlxUoIka1B-JxzXm6RTzVGGeGszTuqF_wDy1MU8V5qmFeaoxb09rink5y_4BOXv39vR46apiJW7BfDa4JZhORc7COEpAxCV-VoCmx-MS7PkiyqvC84qCz1keczb3CmiIi2QRZDmIwBLTi_kPyV4DP-sxoZzhDr-Xg_qas4pFGQ_L2Kv83EvQSyJyyEyzNi1UJn8sKLNK0aIHTKRfCywvm6SICYe8NNQbmcHmGjoKKLmOxJUkhxMIGWK0E0Lf9x1yoDGVqrWgT_0F2lxhEs4d8tw0gxTDo8ms4e3Yp2EEllccxQ55JAG4nYfCs0OiCTQNAebHn7Y09YXIkw-W2TwO2ZNr-3xKbm2XggOyN3QjfwY2xpAfilfuF_EuOaQ |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+and+genetic+heterogeneity%2C+overlap+with+other+tumor+syndromes%2C+and+atypical+glucocorticoid+hormone+secretion+in+adrenocorticotropin-independent+macronodular+adrenal+hyperplasia+compared+with+other+adrenocortical+tumors&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Hsiao%2C+Hui-Pin&rft.au=Kirschner%2C+Lawrence+S&rft.au=Bourdeau%2C+Isabelle&rft.au=Keil%2C+Margaret+F&rft.date=2009-08-01&rft.eissn=1945-7197&rft.volume=94&rft.issue=8&rft.spage=2930&rft_id=info:doi/10.1210%2Fjc.2009-0516&rft_id=info%3Apmid%2F19509103&rft.externalDocID=19509103 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |